Tengion’s Neo-Urinary Conduit Implanted in First Patient

Tengion, Inc. announced Monday that surgeons at the University of Chicago have implanted its Neo-Urinary Conduit in the first patient as part of the ongoing clinical trial evaluating the company’s lead product candidate in bladder cancer patients requiring a urinary diversion following bladder removal.
Forbes